Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses
Research and development	$ 3,798,636	$ 1,653,239	$ 5,177,123	$ 2,591,859
General and administrative	3,205,130	2,282,568	5,357,371	4,280,957
Total operating expenses	7,003,766	3,935,807	10,534,494	6,872,816
Operating loss	(7,003,766)	(3,935,807)	(10,534,494)	(6,872,816)
Other income (expense), net	(35,482)	29,665	(42,823)	19,254
Loss before income taxes	(7,039,248)	(3,906,142)	(10,577,317)	(6,853,562)
Income taxes	0	0	0	0
Net loss	$ (7,039,248)	$ (3,906,142)	$ (10,577,317)	$ (6,853,562)
Loss per common share - basic and diluted (in dollars per share)	$ (0.06)	$ (0.43)	$ (0.10)	$ (0.75)
Weighted average shares outstanding - basic and diluted (in shares)	121,572,091	9,187,588	107,159,698	9,159,286